AI assistant
MYRIAD GENETICS INC — Director's Dealing 2024
Mar 25, 2024
32566_dirs_2024-03-25_8783266c-4f65-40d1-98cc-f247230ca803.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2024-03-22
Reporting Person: Munk Natalie (Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-22 | Common Stock | F | 363 | $22.24 | Disposed | 46365 | Direct |
| 2024-03-24 | Common Stock | F | 401 | $22.24 | Disposed | 45964 | Direct |
| 2024-03-24 | Common Stock | F | 580 | $22.24 | Disposed | 45384 | Direct |
Footnotes
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.
F2: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.